SFI
VRCA icon

SPC Financial Inc’s Verrica Pharmaceuticals VRCA Stock Holding History

SPC Financial Inc’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,000
Closed -$15.9K – 289
2025
Q2 		$15.9K Hold
3,000
– – ﹤0.01% 261
2025
Q1 		$13.3K Hold
3,000
– – ﹤0.01% 261
2024
Q4 		$21K Hold
3,000
– – ﹤0.01% 259
2024
Q3 		$43.5K Hold
3,000
– – ﹤0.01% 252
2024
Q2 		$219K Hold
3,000
– – 0.02% 234
2024
Q1 		$178K Hold
3,000
– – 0.02% 226
2023
Q4 		$220K Hold
3,000
– – 0.02% 215
2023
Q3 		$117K Hold
3,000
– – 0.01% 206
2023
Q2 		$173K Buy
+3,000
New +$182K 0.02% 214

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

SPC Financial Inc's VRCA Position: Q3 2025 in Review

SPC Financial Inc sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 3,000 shares — an estimated $15.9K sold.

SPC Financial Inc first reported a position in VRCA in Q2 2023 and held it in 9 quarters. The position peaked at $220K in Q4 2023. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

  • SPC Financial Inc reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • SPC Financial Inc sold 3,000 Verrica Pharmaceuticals shares in Q3 2025, an estimated $15.9K.
  • SPC Financial Inc first reported a position in Verrica Pharmaceuticals in Q2 2023 and held it in 9 quarters.
  • SPC Financial Inc's Verrica Pharmaceuticals position peaked at $220K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on SPC Financial Inc's 13F filing for Q3 2025, filed 5 Nov 2025.